New research aims to get closer to settling the fierce debate over whether GLP-1s are worth the cost
As a new Medicare program expands access to weight-loss drugs, high costs leave many who could benefit from them shut out.
FIFA has heard the criticism of the sudden decision to reinstate U.S. striker Folarin Balogun for Monday night's game against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results